瞬时弹性成像技术评估替诺福韦联合扶正化瘀胶囊治疗乙型肝炎肝硬化患者疗效初步研究

doi:10.3969/j.issn.1672-5069.2021.01.037

Journal of Practical Hepatology ›› 2021, Vol. 24 ›› Issue (1): 143-144.doi: 10.3969/j.issn.1672-5069.2021.01.037

Previous Articles Next Articles

Clinical efficacy of tenofovir and Fuzhenghuayu capsule in treatment of patients with chronic hepatitis B liver cirrhosis

Ye Xiaoting,Sun Qingfeng,Fu Rongquan, et al

Department of Infectious Diseases, Third Affiliated Hospital, Wenzhou Medical University, Wenzhou 330325, Zhejiang Province, China

Online:2021-01-10 Published:2021-01-19

Abstract

Ye Xiaoting,Sun Qingfeng,Fu Rongquan, et al. Clinical efficacy of tenofovir and Fuzhenghuayu capsule in treatment of patients with chronic hepatitis B liver cirrhosis[J]. Journal of Practical Hepatology, 2021, 24(1): 143-144.

[1]	Song Jinyun, Wang Jianfang, Zhao Hongyu. Hepatitis B viralgenotypes in patients with chronic hepatitis B and cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(1): 87-90.
[2]	Wei Rongrong, Li Ailing, Li Hong, et al. Changes and clinical significance of indocyanine green clearance test in patients with chronic viral hepatitis, liver cirrhosis and liver failure [J]. Journal of Practical Hepatology, 2021, 24(1): 91-94.
[3]	Zhang Xin, Guo Yue, Yang Jun. Evaluation ofesophageal and gastric varices by liver and splenic stiffness measurement by elastography in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(1): 95-98.
[4]	Fan Jing, Xu Jing, Yuan Xue. Combination of rifaximin and lactulose improves clinical efficacy and mortality in hepatitis B cirrhotic patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2021, 24(1): 103-106.
[5]	Wu Xiongfei, Fang Lijuan, Chen Yan.. Short-term efficacy of tenofovir and interferon-α2b combination in the treatment of patients with serum HBeAg-positive chronic hepatitis B [J]. Journal of Practical Hepatology, 2020, 23(5): 638-641.
[6]	Dong Jing,Liu Longmei,Chen Zhaolin,et al.. Efficacy of tenofovir disoproxil fumarate and double plasma molecular absorb system plus plasma exchange in treatment of patients with HBV-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2020, 23(5): 687-690.
[7]	Zeng Yanni, Han Jun, Liu Liangjin, et al.. CT liver perfusion imaging parameters in patients with schistosomiasis-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(5): 691-694.
[8]	Yang Xi, Song Dongmei, Hua Min.. Efficacy and impact on blood coagulation functions of somatostatin and octreotide combination in the treatment of cirrhotic patients with upper gastrointestinal hemorrhage [J]. Journal of Practical Hepatology, 2020, 23(5): 695-698.
[9]	Hu Dengcai, Du Li, Cao Chenhong, et al.. Serum procalcitonin and C-reactive protein levels in predicting spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(5): 699-702.
[10]	Lu Changchun, Ding Minxia, Duan Zuobin, et al.. Therapeutic effect and renal function changes of antiviral therapy from lamivudine andadefovir dipivoxil switch to tenofovir in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(5): 703-706.
[11]	He Liandong, Cao Shuqing, Han Can, et al.. Efficacy of ascites concentration and reinfusion in treatment of patients with decompensated liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(5): 707-710.
[12]	Zhu Xiaoqiang, Jiang Kai, Pan Jing.. Evaluation of hepatic functional reserve using practical liver volumes measured by enhanced CT scan in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(5): 711-714.
[13]	Hao Shasha, Ren Xiaojing, Yuan Lili, et al. Correlation of intestinal microecology to muscle mass loss in patients with liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(4): 462-466.
[14]	Wang Ke, Cui Xianping, Liu Lijuan, et al. Modulation of apoptotic protein expression by blueberry anthocyanin in rats with diethylnitrosamine-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(4): 480-483.
[15]	Zhuo Li, Xu Min, Deng Haohui. Preliminaryobservation of asunaprevir and daclatasvirin combination therapy in patients with chronic hepatitis C and hepatitis C liver cirrhosis and the resistance mutations and quasispecies changes [J]. Journal of Practical Hepatology, 2020, 23(4): 504-507.

Clinical efficacy of tenofovir and Fuzhenghuayu capsule in treatment of patients with chronic hepatitis B liver cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments